![](https://capedge.com/proxy/8-K/0000721748-16-000909/inpt8k010616ex3_1e.jpg)
Filing Fee: $175.00
IMPORTANT: Failure to include any of the above information and submit with the proper fees may cause this filing to be rejected.
This form must be accompanied by appropriate fees.Nevada Secretary of State Stock DesignationRevised: 1-5-15
Attachment to Certificate of Designations for
Integrated Inpatient Solutions, Inc.
The Series B shares are not participating shares and prior to conversion the holders thereof shall not receive any dividend or other distribution from the Corporation and no portion of the Dividend will be distributed for the benefit of the holders of Series B shares. Prior to conversion, however, the holders of Series B shares shall be entitled to vote on all matters on which holders of common stock are entitled to vote and shall vote as if such Series B shares had converted, provided however, that the holders of Series B shares shall not be entitled to vote on any matter which would amend the terms of and restrictions on the Series B shares.
If the Corporation, at any time while this Series B shares are outstanding: (i) subdivides outstanding shares of common stock into a larger number of shares, (ii) combines (including by way of a reverse stock split) outstanding shares of common stock into a smaller number of shares, or (iii) issues, in the event of a reclassification of shares of the common stock, any shares of capital stock of the Corporation, then the number of shares into which the Series B shares are convertible shall simultaneously therewith be changed such that the holders of Series B shares receive the same number of shares of common stock as if conversion into common stock had occurred immediately prior to such event(s). No fractional shares shall be issued upon the conversion of any Series B share or shares, and the number of shares of common stock to be issued shall be rounded to the nearest whole share.